IL10 and COVID-19: Furthermore, after ssRNA and R848 stimulation, patients’ PBMCs released high amounts of IL-10, a predominantly anti-inflammatory/pro-tolerogenic cytokine (Figure S2A), implying that PBMCs might be a prolific source of IL-10, which is also elevated in the sera of COVID-19 patients [27].